3-[(2-Chlorophenyl)methyl]-1,2lambda~4~,3-oxathiazolidin-2-one → N-(2-chlorobenzyl)-2,2-dioxo-1,2,3-oxathiazolidine

HRID 439911

반응식

HRID 439911 반응식
[Cl:1][C:2]1[CH:14]=[CH:13][CH:12]=[CH:11][C:3]=1[CH2:4][N:5]1[CH2:9][CH2:8][O:7][S:6]1=[O:10].Cl[O-:16].[Na+]>O.[Ru](=O)=O>[Cl:1][C:2]1[CH:14]=[CH:13][CH:12]=[CH:11][C:3]=1[CH2:4][N:5]1[CH2:9][CH2:8][O:7][S:6]1(=[O:16])=[O:10]

참가 물질

4

반응물 2

HCID 152277033-[(2-Chlorophenyl)methyl]-1,2lambda~4~,3-oxathiazolidin-2-oneHCID 23665760Sodium Hypochlorite

생성물 1

HCID 15227704N-(2-chlorobenzyl)-2,2-dioxo-1,2,3-oxathiazolidine

시약·촉매·용매 1

HCID 16211523Ruthenium dioxide hydrate촉매

실험 절차

contacting the N-(2-chlorobenzyl)-2-oxo-1,2,3-oxathiazolidine with ruthenium dioxide hydrate and aqueous sodium hypochlorite to give N-(2-chlorobenzyl)-2,2-dioxo-1,2,3-oxathiazolidine,

출처 및 근거

ORD 기록
ord-694307752eff4629a905bc788ca691b5
출처 데이터셋
uspto-grants-1996_05
특허 번호
US05516910

연결된 노트

불러오는 중…